123 related articles for article (PubMed ID: 23304380)
1. Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients.
Yang X; Li H; Regan K; Li J; Huang Y; Lussier YA
AMIA Annu Symp Proc; 2012; 2012():1040-9. PubMed ID: 23304380
[TBL] [Abstract][Full Text] [Related]
2. Single sample expression-anchored mechanisms predict survival in head and neck cancer.
Yang X; Regan K; Huang Y; Zhang Q; Li J; Seiwert TY; Cohen EE; Xing HR; Lussier YA
PLoS Comput Biol; 2012 Jan; 8(1):e1002350. PubMed ID: 22291585
[TBL] [Abstract][Full Text] [Related]
3. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.
Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL
PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.
Wan YW; Beer DG; Guo NL
Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960
[TBL] [Abstract][Full Text] [Related]
5. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
Guo NL; Wan YW
Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
[TBL] [Abstract][Full Text] [Related]
6. An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
Qi L; Li T; Shi G; Wang J; Li X; Zhang S; Chen L; Qin Y; Gu Y; Zhao W; Guo Z
Mol Oncol; 2017 Nov; 11(11):1630-1645. PubMed ID: 28922552
[TBL] [Abstract][Full Text] [Related]
7. Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.
Ringnér M; Staaf J
Oncotarget; 2016 Aug; 7(33):52957-52973. PubMed ID: 27437773
[TBL] [Abstract][Full Text] [Related]
8. Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.
Yao J; Zhao Q; Yuan Y; Zhang L; Liu X; Yung WK; Weinstein JN
PLoS One; 2012; 7(9):e45894. PubMed ID: 23029298
[TBL] [Abstract][Full Text] [Related]
9. 'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.
Gardeux V; Achour I; Li J; Maienschein-Cline M; Li H; Pesce L; Parinandi G; Bahroos N; Winn R; Foster I; Garcia JG; Lussier YA
J Am Med Inform Assoc; 2014; 21(6):1015-25. PubMed ID: 25301808
[TBL] [Abstract][Full Text] [Related]
10. Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma.
Chang YH; Chen CM; Chen HY; Yang PC
Sci Rep; 2015 Jun; 5():10979. PubMed ID: 26042604
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic gene-expression signature for lung adenocarcinoma.
Park YY; Park ES; Kim SB; Kim SC; Sohn BH; Chu IS; Jeong W; Mills GB; Byers LA; Lee JS
PLoS One; 2012; 7(9):e44225. PubMed ID: 22970185
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
[TBL] [Abstract][Full Text] [Related]
13. Curation-free biomodules mechanisms in prostate cancer predict recurrent disease.
Chen JL; Hsu A; Yang X; Li J; Lee Y; Parinandi G; Li H; Lussier YA
BMC Med Genomics; 2013; 6 Suppl 2(Suppl 2):S4. PubMed ID: 23819917
[TBL] [Abstract][Full Text] [Related]
14. Identification of reproducible gene expression signatures in lung adenocarcinoma.
Lu TP; Chuang EY; Chen JJ
BMC Bioinformatics; 2013 Dec; 14():371. PubMed ID: 24369726
[TBL] [Abstract][Full Text] [Related]
15. Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling.
Wu C; Zhang D
Cancer Biomark; 2017; 18(2):117-123. PubMed ID: 27935544
[TBL] [Abstract][Full Text] [Related]
16. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
17. Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.
Zhang Z; Zhang S; Li X; Zhao Z; Chen C; Zhang J; Li M; Wei Z; Jiang W; Pan B; Li Y; Liu Y; Cao Y; Zhao W; Gu Y; Yu Y; Meng Q; Qi L
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32383445
[TBL] [Abstract][Full Text] [Related]
18. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
[TBL] [Abstract][Full Text] [Related]
19. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Zengin T; Önal-Süzek T
BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
[TBL] [Abstract][Full Text] [Related]
20. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
Sun Z; Wigle DA; Yang P
J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
